Clinical Trial Update: Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating once-daily avatrombopag tablets for thrombocytopenia related to chronic liver disease in patients undergoing elective procedures; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease with Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Eisai Inc. | Conditions: Thrombocytopenia Related to Chronic Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23